Latest Corona Vaccine News: Good News In The Fight Against Covid 19 Pfizer Vaccine Proves 90% Effective In Trials

Strong points:

News that sparks hope in fight against Corona, 90% effective in Pfizer vaccine trial US pharmaceutical company Pfizer entered into a partnership with German pharmaceutical company BioNTech on Monday. Hasington
There is great news for the world suffering from the coronavirus pandemic. The Corona Vaccine News from pharmaceutical company Pfizer was found to be 90% effective in the latest clinical trial which turned out to be better than expected. Not only that, if all goes well, by the end of the month, the company can get approval to sell the vaccine. This is certainly very encouraging news to prevent the global epidemic. Pfizer manufactures the Corona vaccine with its partner BioNTech. Pfizer American and BioNTech are German pharmaceutical companies.

The company said on Monday that in its vaccine trial, 90% of 94 people infected were found to be effective. Among those infected, there was at least 1 symptom of Kovid-19. The vaccine is still in the testing phase, but the results hope that soon the way for its use can be cleared around the world. The Corona outbreak has killed more than 1.2 million people worldwide to date and the vaccine is eagerly awaited.

The worst phase of the Corona virus has arrived in Delhi! These scary pictures

US President Donald Trump called this very big news. He tweeted that the vaccine was coming soon. Over 90 percent have been shown to be effective.

The company said the analysis showed that it was over 90% successful in preventing the disease in the volunteers who tested it. If the rest of the data also indicates that the vaccine is safe, the company will seek permission to sell the vaccine from health regulators before the end of this month.

Pfizer said that to date, no serious safety issues have been revealed during clinical trials. The trial tests approximately 44,000 people in the United States and other countries. However, it is not yet clear how long people will develop crown immunity with the vaccine.

The company has reviewed the vaccine trials with a panel of external and independent experts to ensure that the results are fully reliable and that the process is fully transparent. The committee is known as the Data Safety Oversight Committee, which determines the efficacy and safety of the candidate vaccine. The committee shared the results of its interim review of Pfizer and BioNTech.

Back to top button